164 related articles for article (PubMed ID: 1721834)
1. T cell responses to peptides covering the gag p24 region of HIV-1 occur in HIV-1 seronegative individuals.
Vyakarnam A; Matear PM; Cranenburg C; Michie C; Beverley PC; Wahren B; Gill SK; Weller I
Int Immunol; 1991 Oct; 3(10):939-47. PubMed ID: 1721834
[TBL] [Abstract][Full Text] [Related]
2. CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific unresponsiveness.
Dybul M; Mercier G; Belson M; Hallahan CW; Liu S; Perry C; Herpin B; Ehler L; Davey RT; Metcalf JA; Mican JM; Seder RA; Fauci AS
J Immunol; 2000 Aug; 165(3):1685-91. PubMed ID: 10903780
[TBL] [Abstract][Full Text] [Related]
3. Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1.
van Baalen CA; Klein MR; Huisman RC; Dings ME; Kerkhof Garde SR; Geretti AM; Gruters R; van Els CA; Miedema F; Osterhaus AD
J Gen Virol; 1996 Aug; 77 ( Pt 8)():1659-65. PubMed ID: 8760412
[TBL] [Abstract][Full Text] [Related]
4. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
[TBL] [Abstract][Full Text] [Related]
5. Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev.
Blazevic V; Ranki A; Krohn KJ
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1335-42. PubMed ID: 8573390
[TBL] [Abstract][Full Text] [Related]
6. Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays.
Schmitz JL; Denny TN; Garcia A; Lathey JL;
Clin Diagn Lab Immunol; 2002 May; 9(3):525-9. PubMed ID: 11986255
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive T-cell epitope mapping of HIV-1 env antigens reveals many areas recognized by HIV-1-seropositive and by low-risk HIV-1-seronegative individuals.
Mutch D; Underwood J; Geysen M; Rodda S
J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):879-90. PubMed ID: 7519672
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization.
Venturini S; Mosier DE; Burton DR; Poignard P
J Virol; 2002 Jul; 76(14):6987-99. PubMed ID: 12072499
[TBL] [Abstract][Full Text] [Related]
9. Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects.
Roff SR; Sanou MP; Rathore MH; Levy JA; Yamamoto JK
Hum Vaccin Immunother; 2015; 11(6):1540-56. PubMed ID: 25844718
[TBL] [Abstract][Full Text] [Related]
10. Differences among mononuclear cell subpopulations in HIV seropositive or seronegative homosexual and heterosexual men as determined by four-color flow cytometry.
Schnizlein-Bick CT; Magier MR; Jones RB; Fife KH; Katz BP; Walker EB
J Acquir Immune Defic Syndr (1988); 1990; 3(8):747-56. PubMed ID: 2142218
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 variation diminishes CD4 T lymphocyte recognition.
Harcourt GC; Garrard S; Davenport MP; Edwards A; Phillips RE
J Exp Med; 1998 Nov; 188(10):1785-93. PubMed ID: 9815256
[TBL] [Abstract][Full Text] [Related]
12. T cell recognition of HIV synthetic peptides in a natural infection.
Schrier RD; Gnann JW; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA
J Immunol; 1989 Feb; 142(4):1166-76. PubMed ID: 2783706
[TBL] [Abstract][Full Text] [Related]
13. Primary proliferative responses to peptides of HIV Gag p24.
Bedford PA; Clarke LB; Hastings GZ; Knight SC
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Apr; 14(4):301-6. PubMed ID: 9111471
[TBL] [Abstract][Full Text] [Related]
14. Conserved HIV-1 Gag p24 Epitopes Elicit Cellular Immune Responses That Impact Disease Outcome.
Tarosso LF; Vieira VA; Sauer MM; Tomiyama HI; Kalil J; Kallas EG
AIDS Res Hum Retroviruses; 2017 Aug; 33(8):832-842. PubMed ID: 28594230
[TBL] [Abstract][Full Text] [Related]
15. A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection.
Imami N; Pires A; Hardy G; Wilson J; Gazzard B; Gotch F
J Virol; 2002 Sep; 76(18):9011-23. PubMed ID: 12186885
[TBL] [Abstract][Full Text] [Related]
16. Two-year evaluation of clinical and laboratory variables of immune function in 117 hemophiliacs seropositive or seronegative for HIV-1.
Teitel JM; Freedman JJ; Garvey MB; Kardish M
Am J Hematol; 1989 Dec; 32(4):262-72. PubMed ID: 2573270
[TBL] [Abstract][Full Text] [Related]
17. Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles.
Gudmundsdotter L; Bernasconi D; Hejdeman B; Sandstrom E; Alaeus A; Lidman K; Ensoli B; Wahren B; Buttò S
Vaccine; 2008 Sep; 26(40):5182-7. PubMed ID: 18479789
[TBL] [Abstract][Full Text] [Related]
18. Cross-Reactive Potential of HIV-1 Subtype C-Infected Indian Individuals Against Multiple HIV-1 Potential T Cell Epitope Gag Variants.
Negi N; Vajpayee M; Singh R; Sharma A; Murugavel KG; Ranga U; Thakar M; Sreenivas V; Das BK
Viral Immunol; 2016 Dec; 29(10):572-582. PubMed ID: 27875663
[TBL] [Abstract][Full Text] [Related]
19. HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection.
Beretta A; Furci L; Burastero S; Cosma A; Dinelli ME; Lopalco L; DeSantis C; Tambussi G; Carrow E; Sabbatani S; Clerici M; Lazzarin A; Siccardi AG
Immunol Lett; 1996 Jun; 51(1-2):39-43. PubMed ID: 8811343
[TBL] [Abstract][Full Text] [Related]
20. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
